Rankings
▼
Calendar
BLTE FY 2020 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena
BLTE
Belite Bio, Inc
$7B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-0.62
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$26M
Total Liabilities
$33M
Stockholders' Equity
-$7M
Cash & Equivalents
$26M
← Q1 2020
All Quarters